Previous studies report that N. meningitidis serogroup A was the main cause of meningitis. In comparison with other serogroups of N. meningitidis, higher detection rate of serogroup A was expected. Though serogroup A was not detected in the carriage study, it was later isolated in other study focusing on bacterial meningitis patients. Serogroup X was identified for the first time in a consortium study among three site University hospitals in bacterial meningitis disease focusing in detection of etiologic agents in the non-epidemic season. Serogroup W-135 was detected in increased frequency with respect to the relatively smaller sample size of the consortium study. Serogroup W -135, X and Y are also detected in later carriage study. Vaccine clinical trial targeting on serogroup A and serogroup W-135 is planned.
- The Diversity of Meningococcal Carriage acrossthe African Meningitis Belt and the Impact ofVaccination with a Group A Meningococcal Conjugate Vaccine. Journal of Infectious Diseases Advance Access published May 12, 2015. Author name: MenAfriCAR Consortium
- Chronic meningitis in immunocompromised adult Ethiopians visiting TikurAnbessa Teaching Hospital and Ye’huleshet Clinic from 2003-2004.Ethiop Med J,Sup 1,43-47.Jan. 2014. Author Name: WudeMhiret
- A pilot study on detection and genotyping of human papilloma viruse isolated from clinically diagnosed Ethiopian women having cervical intraephitelialneoplasia.Ethiop Med J,Sup 1,49-51. Jan. 2014. Author Name: WudeMhiret
- Meningococcal carriage in the African meningitis belt.Tropical Medicine and International Health18:8 968–978 August 2013. Author Name: MenAfriCAR Consortium
- Household Crowding, Social Mixing Patterns and Respiratory Symptoms in Seven Countries of the AfricanMeningitis Belt.www.plosone.org. July 2014 | Volume 9 | Issue7 Author Name: Claire F. Ferraro et al. 2014